Cargando…
Systematic review: IL-12/23 or IL-23 antagonists and RTIs or ILD
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7453847/ http://dx.doi.org/10.1007/s40278-020-82554-0 |
Ejemplares similares
-
The Dichotomous Pattern of IL-12R and IL-23R Expression Elucidates the Role of IL-12 and IL-23 in Inflammation
por: Chognard, Gaëlle, et al.
Publicado: (2014) -
Successful treatment with the IL12/IL23 antagonist ustekinumab in a patient with refractory Takayasu arteritis
por: Saur, Sebastian-Jonas, et al.
Publicado: (2021) -
No Significant Reduction of Circulating Endothelial-Derived and Platelet-Derived Microparticles in Patients with Psoriasis Successfully Treated with Anti-IL12/23
por: Ho, Ji-Chen, et al.
Publicado: (2016) -
Manifestations of cutaneous mycobacterial infections in patients with inborn errors of IL-12/IL-23-IFNγ immunity
por: Dolezalova, Karolina, et al.
Publicado: (2022) -
Effects of early enteral nutrition on Th17/Treg cells and IL-23/IL-17 in septic patients
por: Sun, Jia-Kui, et al.
Publicado: (2019)